Tratamiento del infarto del miocardio en la unidad de cuidado intensivo, Hospital San Juan de Dios, Bogotá
Treatment of patients with infarct of the myocardium in the intensive care unit of the San Juan de Dios Hospital, Bogota
Loading...
Cite
Date
s.d., 1971
Document Number
ISBN
eISBN
ISSN
DOI
Other Language Versions
Description
The design, organization, operation, admission criteria and handling of patients with infarct of the myocardium in the Intensive Care Unit of the San Juan de Dios Hospital in Bogota is described. Between 3 February 1969 and 3 February 1970, 496 patients were admitted to the Intensive Care Unit. Forty-three of these patients (8.6 per cent) were diagnosed as having infarct of the myocardium. The average age of these patients was 53.7 years. Their average stay was 4.7 days. The mortality rate in the Intensive Care Unit was 16 per cent and the final mortality rate was 30 per cent. The latter percentage compares favorably with figures of 44.4 per cent and 47 per cent observed during the years 1967 and 1968, respectively. The most frequent cause of death was cardiogenic shock, untreatable failure of the left ventricle, asystole and myocardiac rupture for which there is not effective form of therapy at present. The most frequent complications were arrhythmias (65 per cent) and congestive cardiac insufficiency (51 per cent). The most frequent arrhythmias were: premature ventricular contractions (53.5 per cent), sinus tachycardia (46.5 per cent), second and third degree auricular-ventricular blocks (20.9 per cent) and ventricular tachycardia (11.6 per cent). The favorable results of the aggressive handling of the arrhythmias were evidenced by the release from the hospital of all patients with ... (AU)
Notes
Pages
Volume
Replaces
Table of contents
Link to WHO's original document
Link to WHO's original document
Category
Youtube URI
Citation
Status Mendates
Collections
License
Related items
Showing items related by metadata.
Item Prevalencia de factores de riesgo cardiovascular en una población adulta ambulatoria urbana: estudio AsuRiesgo, Paraguay(2015)Objetivo. Las enfermedades cardiovasculares son la principal causa de mortalidad en el mundo. Aunque la mayoría son prevenibles, su prevalencia sigue aumentando. El objetivo de este estudio fue estimar la prevalencia de factores de riesgo cardiovascular en una población hospitalaria ambulatoria urbana y adulta de Asunción, Paraguay. Métodos. Se realizó un análisis transversal de todos los pacientes incluidos en el estudio prospectivo de prevención cardiovascular AsuRiesgo dirigido al cambio del estilo de vida a un estilo de vida saludable. Se invitó a participar a personas de 18 y más años de edad que se encontraban en las zonas de espera de consultorios de un hospital terciario. Se obtvuvo información anamnésica, antropométrica y de laboratorio. Resultados. Se incluyeron 18 287 pacientes de 51 ± 16 años de edad, de los cuales 67,5% fueron mujeres. La media de peso corporal fue 77,5 ± 16,2 kg y el índice de masa corporal, 29,7 ± 5,9 kg/m². Las prevalencias de antecedentes de infarto de miocardio, accidente vascular cerebral, diabetes mellitus e hipertensión fueron, respectivamente, 2,6, 3, 13,3 y 53%, y las del hábito de fumar, dieta no saludable, sedentarismo y estrés psicológico, 29,3, 41,2, 58,2 y 56,6%. Por último, la prevalencia global de obesidad y sobrepeso fue 79,6%, las de prehipertensión e hipertensión arterial sistémica, 39 y 25%, respectivamente, y la del síndrome metabólico, 34,7%. Conclusiones. Si bien las prevalencias del hábito de fumar, hipertensión arterial sistémica y diabetes mellitus fueron bajas, las de obesidad, sedentarismo, estrés psicológico, dieta no saludable y síndrome metabólico fueron muy elevadas, lo cual justifica una acción global para prevenir discapacidades o fallecimientos por enfermedad isquémica cardiaca o cerebral. La implementación urgente de los programas con estos fines a escala nacional es imperativa.Item Regional Update, Influenza. Epidemiological Week 14 (19 April 2022)(PAHO, 2022)[WEEKLY SUMMARY]. North America: Overall, influenza activity remained at low levels. SARS-CoV-2 activity continued to decline, and SARS-CoV-2 percent positivity remained at low levels. In Canada, influenza activity continued low, and SARS-CoV-2 activity slightly increased. In Mexico, influenza activity has decreased below the average of previous seasons, and the SARS-CoV-2 activity declined. In the United States, influenza activity increased at the national level, with Influenza A(H3N2) viruses predominating. SARS-CoV-2 activity, including mortality, continued to decline. Caribbean: Influenza activity remained at low levels overall, with influenza A(H3N2) predominant. SARS-CoV-2 activity continued to decline overall. Central America: Overall, influenza activity remained low and SARS-CoV-2 activity decreased in most countries. In Nicaragua, influenza percent positivity remained stable at low-intensity levels. In El Salvador, influenza activity remained above average at low-intensity levels. Andean: Overall, influenza activity continued low with a few A(H3N2) detections. SARS-CoV-2 activity continued to decrease in most countries. In Peru, influenza percent positivity increased at low-intensity levels. RSV activity increased in Ecuador. Brazil and Southern Cone: Overall, influenza activity with A(H3N2) predominance and SARS-CoV-2 activity continued to decrease in most countries. In Chile, influenza percent positivity was above the previous season’s average within the reference levels, and SARS-CoV-2 activity decreased. In Brazil, RSV activity increased. Global: Influenza activity remained low, but activity has increased since February 2022, after an initial decrease in January 2022. In the temperate zones of the northern hemisphere, influenza activity increased or remained stable, except in East Asia, where detections decreased. Detections were mainly influenza A(H3N2) viruses and B/Victoria lineage viruses. In Europe, overall influenza activity has stabilized with influenza A(H3N2) predominant. Very little RSV activity was observed. In Central Asia, a single influenza B detection was reported in Kyrgyzstan. In East Asia, influenza activity with mainly influenza B/Victoria lineage detections appeared to decrease in China. ILI rate and pneumonia hospitalizations remained elevated in Mongolia. Elsewhere, influenza illness indicators and activity remained low. In Northern Africa, increasing influenza A(H3N2) detections were reported in Tunisia. In Western Asia, influenza activity was low across reporting countries, except Georgia, where increased influenza A(H3N2) detections were reported. In tropical Africa, influenza activity was reported mainly from Eastern Africa, with influenza A(H3N2) predominating, followed by influenza B/Victoria lineage viruses. In Southern Asia, influenza virus detections were at low levels with influenza A(H1N1)pdm09 and A(H3N2) viruses. In South-East Asia, influenza detections were at low levels except in Timor-Leste, with influenza A(H3N2) predominant. In the temperate zones of the southern hemisphere, influenza activity remained low overall. However, detections of influenza A viruses (with A(H3N2) predominant among the subtyped viruses) continued to be reported in South Africa. SARS-CoV-2 percent positivity from sentinel surveillance was around 10.0% in all regions during this reporting period. Percent positivity decreased in all regions except in the South-East Asian region, where it increased, and in the Eastern Mediterranean Region, where there was a slight uptick. Overall positivity from non-sentinel sites also showed a decreasing trend.Item Profile of Brazilian inpatients with COVID-19 vaccine breakthrough infection and risk factors for unfavorable outcome(2022)[ABSTRACT]. Objective. To characterize the epidemiological and clinical profile of individuals more likely to become infected with SARS-CoV-2 after the fully vaccination schedule in order to profile priority groups to receive a booster dose in situations of vaccine doses shortage as well as for maintenance of personal protective care. Methods. This cross-sectional study used data from hospitalized COVID-19 patients aged ≥18 years, who had been fully vaccinated and had a SARS-CoV-2 infection positive diagnosis collected from the SIVEP-Gripe database (Influenza Epidemiological Surveillance Information System) from January 18, 2021 to September 15, 2021. Demographic data, clinical symptoms and preexisting medical conditions (comorbidities) were analyzed. The primary outcome was in-hospital death. Results. The majority of hospitalized patients with vaccine breakthrough infection were ≥60 years old, male, with critical or severe COVID-19. The fatality rate was extremely high (50.27%) and more pronounced in elderly groups. The most prevalent symptoms were cough, dyspnea, respiratory distress, and low blood oxygen saturation. The most frequent comorbidities were heart disease and diabetes. High fatality rates were observed among patients admitted to the intensive care units (72.88%) and those who required invasive mechanical ventilation (87.82%). The main risk factors for an unfavorable outcome were older age, respiratory compromise, inactivated virus vaccine immunization, and preexisting medical conditions. Conclusions. We characterized the profile of hospitalized Brazilian patients with COVID-19 vaccine breakthrough infection and the risk factors for an unfavorable outcome. These data allow to identify priority groups to receive a booster dose and to continue using personal protection.